Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis (Q43989705)

28 November 2017

title

Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis (English)

1 reference

28 November 2017

0 references

1 reference

1 reference

Schaad UB

1 reference

28 November 2017

Wedgwood-Krucko J

series ordinal

1 reference

28 November 2017

Suter S

series ordinal

1 reference

28 November 2017

Kraemer R

series ordinal

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 October 1987

1 reference

The Journal of Pediatrics

28 November 2017

published in

1 reference

28 November 2017

volume

111

1 reference

28 November 2017

1 reference

28 November 2017

page(s)

599-605

1 reference

The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Management of acute pulmonary exacerbations in cystic fibrosis: a critical appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Antibiotic use in cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Antibiotic therapy in cystic fibrosis: evaluation of clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Inhaled antibiotics in cystic fibrosis: is there a therapeutic effect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Assay of ceftazidime in biological fluids using high-pressure liquid chromatography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

The systematic evaluation of the chest radiograph in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Reversibility of lung function abnormalities in children with perennial asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Cephalosporin therapeutics in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Acute pulmonary exacerbations in cystic fibrosis. A double-blind trial of tobramycin and placebo therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Pulmonary deposition of aerosols in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

The art and science of the use of antibiotics in cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(87)80130-0

1 reference

28 November 2017

1 reference